{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T16:49:47Z","timestamp":1790700587634,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/j.canrad.2022.05.003","type":"journal-article","created":{"date-parts":[[2022,8,11]],"date-time":"2022-08-11T08:11:33Z","timestamp":1660205493000},"page":"31-41","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors"],"prefix":"10.1016","volume":"27","author":[{"given":"E.","family":"Le Reun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Casutt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Durham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Bouchaab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Krueger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Von Garnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.M.","family":"\u00d6zsahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Kinj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2022.05.003_bib0160","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1001\/jamaoncol.2019.2996","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-Adjusted life-years for 29 cancer groups, 1990 to 2017: a systematic analysis for the global burden of disease study","volume":"5","author":"Global Burden of Disease Cancer Collaboration","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0165","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.1200\/JCO.2010.30.0731","article-title":"Impact of introducing stereotactic lung radiotherapy for elderly patients with stage I non-small-cell lung cancer: a population-based time-trend analysis","volume":"28","author":"Palma","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0170","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1093\/annonc\/mds081","article-title":"Early-stage lung cancer in elderly patients: a population-based study of changes in treatment patterns and survival in the Netherlands","volume":"23","author":"Haasbeek","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0175","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1093\/ejcts\/ezx410","article-title":"The great debate flashes: surgery versus stereotactic body radiotherapy as the primary treatment of early-stage lung cancer","volume":"53","author":"Weder","year":"2018","journal-title":"Eur J Cardio-thoracic Surg"},{"key":"10.1016\/j.canrad.2022.05.003_bib0180","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.radonc.2017.05.012","article-title":"ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer","volume":"124","author":"Guckenberger","year":"2017","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0185","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.prro.2017.06.011","article-title":"Never too old: a single-institution experience of stereotactic body radiation therapy for patients 90 years and older with early stage lung cancer","volume":"7","author":"Videtic","year":"2017","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0190","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdx222","article-title":"Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"28","author":"Postmus","year":"2017","journal-title":"Ann Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0195","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1016\/S0140-6736(18)32487-5","article-title":"Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial","volume":"393","author":"Palma","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.canrad.2022.05.003_bib0200","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.canrad.2007.09.146","article-title":"[CyberKnife robotic stereotactic radiotherapy: technical aspects and medical indications]","volume":"11","author":"Bondiau","year":"2007","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2022.05.003_bib0205","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1177\/153303461000900502","article-title":"The CyberKnife\u00ae robotic radiosurgery system in 2010","volume":"9","author":"Kilby","year":"2010","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/j.canrad.2022.05.003_bib0210","unstructured":"National Cancer Institute: Common terminology criteria for adverse events (CTCAE). Events (CTCAE).v.5.0 [https:\/\/ctep.cancer.gov\/protocolDevelopment\/electronic_applications\/ctc.htm#ctc_50]. 2017 Nov 27:155-150."},{"key":"10.1016\/j.canrad.2022.05.003_bib0215","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20200256","article-title":"A comparison of two modalities of stereotactic body radiation therapy for peripheral early-stage non-small cell lung cancer: results of a prospective French study","volume":"93","author":"Claude","year":"2020","journal-title":"Br J Radiol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0220","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bulcan.2021.10.008","article-title":"[Place of Linacs in extracranial stereotactic radiotherapy: are they now equivalent to Cyberknife\u00ae?.]","volume":"109","author":"Dupic","year":"2022","journal-title":"Bull Cancer"},{"key":"10.1016\/j.canrad.2022.05.003_bib0225","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/tlcr.2018.12.12","article-title":"Empiric radiotherapy for lung cancer collaborative group multi-institutional evidence-based guidelines for the use of empiric stereotactic body radiation therapy for non-small cell lung cancer without pathologic confirmation","volume":"8","author":"Berman","year":"2018","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.canrad.2022.05.003_bib0230","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.lungcan.2012.01.006","article-title":"Stereotactic body radiotherapy (SBRT) for solitary pulmonary nodules clinically diagnosed as lung cancer with no pathological confirmation: Comparison with non-small-cell lung cancer","volume":"77","author":"Takeda","year":"2012","journal-title":"Lung Cancer"},{"key":"10.1016\/j.canrad.2022.05.003_bib0235","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.radonc.2011.09.017","article-title":"Outcomes of stereotactic ablative radiotherapy following a clinical diagnosis of stage i NSCLC: Comparison with a contemporaneous cohort with pathologically proven disease","volume":"101","author":"Verstegen","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0240","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/S1470-2045(21)00401-0","article-title":"STARS Lung Cancer Trials Group Stereotactic ablative radiotherapy for operable stage I non-small-cell lung cancer (revised STARS): long-term results of a single-arm, prospective trial with prespecified comparison to surgery","volume":"22","author":"Chang","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0245","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1378\/chest.122.3.1037","article-title":"Prognostic factors in non-small cell lung cancer: a decade of progress","volume":"122","author":"Brundage","year":"2002","journal-title":"Chest"},{"key":"10.1016\/j.canrad.2022.05.003_bib0250","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13014-018-1016-z","article-title":"The risk and predictors for severe radiation pneumonitis in lung cancer patients treated with thoracic reirradiation","volume":"13","author":"Ren","year":"2018","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0255","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1186\/s12885-020-6635-8","article-title":"Stereotactic body radiotherapy (SBRT) in patients with lung metastases-prognostic factors and long-term survival using patient self-reported outcome (PRO)","volume":"20","author":"Kessel","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.canrad.2022.05.003_bib0260","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13014-021-01769-7","article-title":"Lung stereotactic body radiation therapy for elderly patients aged \u2265 80\u00a0years with pathologically proven early-stage non-small cell lung cancer: a retrospective cohort study","volume":"16","author":"Watanabe","year":"2021","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0265","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.3390\/curroncol28040233","article-title":"Current evidence for stereotactic body radiotherapy in lung metastases","volume":"28","author":"Guti\u00e9rrez","year":"2021","journal-title":"Curr Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0270","doi-asserted-by":"crossref","first-page":"3623","DOI":"10.3390\/cancers13143623","article-title":"Stereotactic body radiotherapy for patients with lung oligometastatic disease: a five-year review","volume":"13","author":"Virbel","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2022.05.003_bib0275","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.ijrobp.2016.03.024","article-title":"Simple factors associated with radiation-induced lung toxicity after stereotactic body radiation therapy of the thorax: a pooled analysis of 88 studies","volume":"95","author":"Zhao","year":"2016","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.05.003_bib0280","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.21037\/tlcr-20-860","article-title":"Stereotactic radiotherapy for early stage non-small cell lung cancer: current standards and ongoing research","volume":"10","author":"Badra","year":"2021","journal-title":"Transl Lung Cancer Res"},{"key":"10.1016\/j.canrad.2022.05.003_bib0285","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.3389\/fonc.2020.01577","article-title":"Significant correlation between overall survival and mean lung dose in lung stereotactic body radiation therapy (SBRT)","volume":"10","author":"Dupic","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0290","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ijrobp.2010.09.020","article-title":"Dose-volume metrics associated with radiation pneumonitis after stereotactic body radiation therapy for lung cancer","author":"Matsuo","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2022.05.003_bib0295","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.radonc.2020.12.015","article-title":"Clinical and dosimetric predictors of radiation pneumonitis in early-stage lung cancer treated with Stereotactic Ablative radiotherapy (SABR) - An analysis of UK's largest cohort of lung SABR patients","volume":"156","author":"Saha","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0300","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/j.cllc.2020.06.006","article-title":"Clinical outcomes and predictors of lung toxicity after multiple courses of lung stereotactic body radiotherapy for early-stage non-small cell lung cancer","volume":"22","author":"Muller","year":"2021","journal-title":"Clin Lung Cancer"},{"key":"10.1016\/j.canrad.2022.05.003_bib0305","first-page":"85","article-title":"Stereotactic lung reirradiation for local relapse: a case series","volume":"28","author":"Kinj","year":"2021","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2022.05.003_bib0310","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.radonc.2019.08.010","article-title":"Repeat stereotactic body radiation therapy (SBRT) for salvage of isolated local recurrence after definitive lung SBRT","volume":"142","author":"Kennedy","year":"2020","journal-title":"Radiother Oncol"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321822001007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:36:41Z","timestamp":1761136601000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321822001007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S1278321822001007"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2022.05.003","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lung stereotactic radiation therapy: Intercomparison of irradiation devices in terms of outcome and predictive factors","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2022.05.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Masson SAS on behalf of Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO).","name":"copyright","label":"Copyright"}]}}